Tag Archives: targeted therapy
New treatments for breast cancer
Now that 90% of women diagnosed with breast cancer will live at least 5 years, new treatments are aim at improving outcomes for the 10% who are not responding to current drugs and delivering treatments with less
New promises from targeting stromal-cancer cell crosstalk in glioblastoma
Glioblastoma (GB) is the most frequent primary brain tumor in adults. The prognosis of GB is poor: median survival time is less than one year since the diagnosis and patients usually die within two years. Standard therapy,
Treatment holidays for patients with metastatic kidney cancer
Targeted therapy is the standard treatment of patients with metastatic cancer of the kidney. The best current therapies target the tumour vasculature thereby blocking the access of the tumour to nutrients and limiting possibility of spreading to
Demyelination and remyelination signalling in multiple sclerosis as an aid to targeted therapy
Multiple sclerosis (MS) is an inflammatory autoimmune disease of the central nervous system (CNS) characterised by demyelination. Demyelination, i.e. damage and erosion of the myelin sheath which protects the nerve fibres, occurs in the white matter of
